Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

TESORIERE, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.696
EU - Europa 3.279
AS - Asia 2.473
SA - Sud America 334
AF - Africa 84
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 10.874
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.638
SG - Singapore 854
RU - Federazione Russa 727
CN - Cina 716
IT - Italia 688
FI - Finlandia 499
UA - Ucraina 363
VN - Vietnam 263
BR - Brasile 254
HK - Hong Kong 226
DE - Germania 220
IE - Irlanda 172
PL - Polonia 140
GB - Regno Unito 118
FR - Francia 109
JP - Giappone 93
SE - Svezia 79
BD - Bangladesh 46
KR - Corea 37
RO - Romania 37
TR - Turchia 33
IN - India 32
NL - Olanda 31
CA - Canada 29
CI - Costa d'Avorio 25
IQ - Iraq 24
IR - Iran 23
AR - Argentina 21
MX - Messico 20
BE - Belgio 19
CO - Colombia 18
PK - Pakistan 18
ZA - Sudafrica 18
AT - Austria 15
ES - Italia 15
ID - Indonesia 13
MY - Malesia 12
VE - Venezuela 12
SA - Arabia Saudita 11
CH - Svizzera 10
NP - Nepal 10
UZ - Uzbekistan 9
EC - Ecuador 8
KE - Kenya 8
MA - Marocco 8
CL - Cile 7
JO - Giordania 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
TN - Tunisia 6
DZ - Algeria 5
GR - Grecia 5
HN - Honduras 5
KZ - Kazakistan 5
PH - Filippine 5
PT - Portogallo 5
AZ - Azerbaigian 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
GE - Georgia 4
PY - Paraguay 4
UY - Uruguay 4
EG - Egitto 3
EU - Europa 3
IL - Israele 3
LB - Libano 3
LT - Lituania 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
AL - Albania 2
CG - Congo 2
ET - Etiopia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
MM - Myanmar 2
MT - Malta 2
NG - Nigeria 2
PE - Perù 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
IS - Islanda 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
OM - Oman 1
PA - Panama 1
SY - Repubblica araba siriana 1
Totale 10.873
Salva come PNG Salva come JPEG
Città #
Singapore 562
Ashburn 557
Fairfield 409
Chandler 318
Woodbridge 272
Houston 269
San Jose 235
Hong Kong 218
Wilmington 214
Jacksonville 202
Seattle 170
Dublin 157
Ann Arbor 155
Beijing 146
Palermo 134
Zgierz 122
Cambridge 119
Medford 103
Dallas 92
Moscow 90
Des Moines 89
Ho Chi Minh City 89
Nanjing 88
Tokyo 88
New York 75
Council Bluffs 71
Los Angeles 66
Hanoi 65
Princeton 63
Frankfurt am Main 62
The Dalles 62
Santa Clara 59
Lauterbourg 51
Tulsa 47
Dearborn 42
Boardman 35
Changsha 34
Jinan 33
Altamura 30
Hefei 28
Helsinki 26
Abidjan 25
Lawrence 25
Hebei 24
Shenyang 24
Buffalo 23
Nanchang 23
San Diego 23
São Paulo 21
Brussels 19
Guangzhou 19
Orem 19
Tianjin 19
Chicago 18
Amsterdam 17
Jiaxing 17
Milan 17
Da Nang 16
Verona 16
Baghdad 14
Atlanta 13
Bremen 13
London 13
Hangzhou 12
Menlo Park 12
Zhengzhou 12
Düsseldorf 11
Napoli 11
City of London 10
Haiphong 10
Johannesburg 10
Kraków 10
Ludwigshafen am Rhein 10
Rio de Janeiro 10
Rome 10
Seoul 10
Venice 10
Ankara 9
Denver 9
Brasília 8
Brooklyn 8
Columbus 8
Frankfurt 8
Ninh Bình 8
Saint Petersburg 8
Tashkent 8
Tehran 8
Cardiff 7
Istanbul 7
Izmir 7
Montreal 7
Toronto 7
Warsaw 7
Amman 6
Belo Horizonte 6
Can Tho 6
Dhaka 6
Lanzhou 6
Monreale 6
Ningbo 6
Totale 6.479
Salva come PNG Salva come JPEG
Nome #
THE APOPTOTIC EFFECT INDUCED IN HepG2 CELLS BY INHIBITORS OF HISTONE DEACETYLASES IS CORRELATED WITH ACETYLATION OF p53 AND HISTONES. 413
Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis 283
Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. 251
JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways 248
SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib. 247
Retinoblastoma: History of His Identification, Characterization and Treatment 241
Staurosporine-induced apoptosis in Chang liver cells is associated with down-regulation of Bcl-2 and Bcl-XL. 239
Differentiative pathway activated by 3-aminobenzamide, an inhibitor of PARP, in human osteosarcoma MG-63 cells. 238
Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment. 235
Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects. 234
The Synergistic Effect of SAHA and Parthenolide in MDA-MB231 Breast Cancer Cells 226
Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma. 216
Hsp72 controls bortezomib-induced HepG2 cell death via interaction with pro-apoptotic factors. 212
COINVOLGIMENTO DELLO STRESS DEL RETICOLO E DEL PROCESSO AUTOFAGICO NELL’APOPTOSI INDOTTA DAL CANNABINOIDE SINTETICO WIN IN CELLULE DI EPATOMA UMANO IN COLTURA 210
3AB-OS, a new human pluripotent cancer stem cell: properties and expectations for practical applications. 207
Differentiation of human osteosarcoma 3AB-OS stem-like cells in derivatives of the three primary germ layers as an useful in vitro model to develop several purposes 207
Parthenolide induces caspase-independent cell death in osteosarcoma, melanoma and breast cancer cells through the induction of oxidative stress. 200
Bortezomib induces in HepG2 cells IkappaBalpha degradation mediated by caspase-8. 199
The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation 198
Histone deacetylase inhibitors: apoptotic effects and clinical implications (Review). 198
Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells 194
Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation. 192
Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. 189
Composizioni farmaceutiche per il trattamento di tumori epatici 188
Janus-Faced role of microRNA let-7d in osteosarcoma 3AB-OS cancer stem cells 188
The HDAC inhibitor SAHA synergistically stimulates the cytotoxic effect induced by Parthenolide in MDA-MB231 cells 187
Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL. 186
The role of oxidative stress in apoptosis induced by the histone deacetylase inhibitor suberoylanilide hydroxamic acid in human colon adenocarcinoma HT-29 cells. 185
THE ROLE OF THE EXTRINSIC PATHWAY OF APOPTOSIS IN THE EFFECT INDUCED BY SAHA IN HUMAN HEPATOMA CELLS. 175
WIN55,212-2, a synthetic agonist of cannabinoid receptors, sensitizes tumor cells to TRAIL-induced apoptosis. 169
THE APOPTOTIC EFFECT EXERTED IN HUMAN HEPATOMA CELLS BY THE INHIBITOR OF HISTONE DEACETYLASE SAHA EITHER ALONE OR IN COMBINATION WITH BORTEZOMIB. 169
Parthenolide sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis 168
Paclitaxel and beta-lapachone synergistically induce apoptosis in human retinoblastoma Y79 cells by downregulating the levels of phospho-Akt. 168
Unusual roles of caspase-8 in triple-negative breast cancer cell line MDA-MB-231 167
Histone deacetylase inhibitors in cancer therapy: Biological and clinical implications. 166
APOPTOTIC EFFECTS INDUCED BY ANANDAMIDE IN HEPATIC CELLS. 163
Histone deacetylase inhibitors: Epigenetic drugs acting by pleiotropic apoptotic mechanism in tumor cells and highly potent in combination with other antitumor agents. 163
The cytotoxic effect exerted by parthenolide and DMAPT on breast cancer stem-like cells 161
HISTONE DEACETYLASE INHIBITORS SENSITIZE HEPATOMA CELLS TO TRAIL_INDUCED APOPTOSIS 157
The mechanism by which histone deacetylase inhibitors sensitize hepatoma and colon cancer cells to TRAIL-induced apoptosis 153
SYNERGISTIC APOPTOTIC INTERACTION BETWEEN THE HDAC INHIBITOR SAHA AND THE PROTEASOME INHIBITOR BORTEZOMIB IN HUMAN HEPATOMA CELLS. 152
The synergistic effect exerted by the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide on triple negative breast canc er cells 150
Degradation of IkBalfa during apoptosis induced by proteasome inhibitors in hepatoma cells. 149
Synergistic interaction between Parthenolide and TRAIL induces apoptosis in human hepatocarcinoma cells. 148
Il partenolide sensibilizza le cellule di epatocarcinoma all'apoptosi indotta da TRAIL 140
Okadaic acid-Parthenolide combination at subtoxic doses induces potent synergistic apoptotic effects in human retinoblastoma Y79 cells by upregulating PTEN. 139
Synergistic apoptotic effect in HepG2 cells between bortezomib and hystone deacetylase inhibitors 137
JNK AND AP-1 MEDIATE APOPTOSIS INDUCED BY BORTEZOMIB IN HEPATOMA HEPG2 CELLS. 132
Proteasome inhibitor Velcade induces apoptosis in hepatoma HepG2 cells stimulating both the extrinsic and the intrinsic apoptotic pathways. 130
The proteasome inhibitor bortezomib in programmed cell death and cancer therapy 130
Quaderni del Dottorato di Ricerca in Oncobiologia Sperimentale: Tecniche e Procedure di Ricerca 130
Differentiative pathway induced by 3-aminobenzamide in MG-63 human osteosarcoma cells. 129
New perspectives in tumor therapy: molecular aspects, 2006 128
Synergistic effect of the HDAC inhibitor SAHA and the sesquiterpene lactone parthenolide in triple negative breast cancer cells. 124
Role of the acetylation of p53 and histones in SAHA-induced apoptosis in human hepatoma HepG2 cells. 123
The synthetic cannabinoid WIN sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by activating p8/CHOP/DR5 axis. 123
Role of PPARγ in apoptosis induced by cannabinoids in hepatoma HepG2 cells. 120
The transcription factor CHOP is critical for WIN-mediated DR5 up-regulation in apoptosis induced by WIN/TRAIL co-treatment in hepatoma cells 117
The involvement of the c-Jun/JNK/AP-1 pathway and HSPs in apoptosis induced by the proteasome inhibitor PS-341 (Velcade) in human hepatoma cells. 116
The cannabinoid WIN induces DR5 receptor expression in hepatoma cells sensitizing them to TRAIL signal 112
Synergistic effects induced by combinations of the synthetic cannabinoid WIN55,212-2 and the death receptor ligand TRAIL in hepatoma HepG2 cells. 110
SAHA induces acetylation of p53 and histones in human hepatoma HepG2 cells 105
THE CANNABINOID AGONIST WIN55,212-2 INDUCES APOPTOSIS IN HUMAN HEPATOMA CELLS. 104
Totale 11.138
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.672
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 0 89 82
2021/2022643 39 156 13 18 10 15 20 22 98 98 24 130
2022/2023885 107 113 18 110 97 153 65 66 96 2 48 10
2023/2024397 20 65 24 47 31 85 25 34 6 3 9 48
2024/20251.004 20 86 59 70 42 55 53 50 51 99 160 259
2025/20263.913 280 143 251 240 377 592 571 442 279 572 166 0
Totale 11.138